Philippe Conus Selected Research

Valproic Acid (Depakote)

1/2024	Associations of Valproate Doses With Weight Gain in Adult Psychiatric Patients: A 1-Year Prospective Cohort Study.
1/2022	Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Conus Research Topics

Disease

50	Psychotic Disorders (Schizoaffective Disorder) 04/2024 - 05/2003
28	Weight Gain 03/2024 - 05/2003
23	Schizophrenia (Dementia Praecox) 01/2024 - 10/2005
7	Mania (Manias) 01/2022 - 10/2006
6	Substance-Related Disorders (Drug Abuse) 01/2024 - 08/2006
6	Bipolar Disorder (Manic Depressive Psychosis) 01/2024 - 10/2005
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2011
4	Hypercholesterolemia 11/2021 - 01/2018
3	Genetic Risk Score 01/2024 - 12/2017
3	Neuroinflammatory Diseases 12/2022 - 11/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 01/2019
3	Mental Disorders (Mental Disorder) 11/2021 - 07/2008
3	Hypertriglyceridemia 11/2021 - 01/2018
3	Dyslipidemias (Dyslipidemia) 01/2019 - 12/2017
2	Obesity 01/2024 - 10/2015
2	Inflammation (Inflammations) 01/2023 - 11/2021
2	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2022 - 01/2022
1	Disease Progression 01/2022
1	Personality Disorders (Personality Disorder) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Infections 01/2022
1	Hyperglycemia 01/2022
1	Abdominal Obesity 01/2022
1	Sleep Wake Disorders 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Hyperprolactinemia 01/2020
1	Torsades de Pointes (Torsade de Pointes) 01/2019
1	Overweight 01/2018

Drug/Important Bio-Agent (IBA)

25	Polytetrafluoroethylene (Teflon)FDA Link 10/2023 - 01/2005
20	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2024 - 10/2013
19	Antipsychotic Agents (Antipsychotics)IBA 03/2024 - 05/2003
9	Glutathione (Reduced Glutathione)IBA 01/2019 - 10/2007
7	tyrosyl- 1,2,3,4- tetrahydro- 3- isoquinolinecarbonyl- phenylalanyl- phenylalanine (TIPP)IBA 04/2024 - 08/2013
7	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2011
6	Olanzapine (Zyprexa)FDA Link 04/2022 - 06/2002
5	Clozapine (Clozaril)FDA LinkGeneric 01/2023 - 06/2002
5	LipidsIBA 01/2022 - 12/2017
5	Cysteine (L-Cysteine)FDA Link 10/2021 - 08/2008
4	Glutamic Acid (Glutamate)FDA Link 12/2022 - 01/2016
4	CholesterolIBA 01/2022 - 12/2017
4	AntioxidantsIBA 10/2021 - 10/2018
4	Acetylcysteine (Siran)FDA LinkGeneric 10/2018 - 07/2011
4	EnzymesIBA 01/2016 - 10/2007
3	HDL LipoproteinsIBA 01/2024 - 12/2017
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 08/2008
3	ParvalbuminsIBA 01/2022 - 01/2019
3	Quetiapine Fumarate (Seroquel)FDA Link 11/2021 - 10/2006
3	oxidized low density lipoproteinIBA 11/2021 - 12/2017
3	Triglycerides (Triacylglycerol)IBA 01/2019 - 09/2017
3	Glutamate-Cysteine LigaseIBA 01/2016 - 10/2007
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2024 - 01/2022
2	LithiumIBA 01/2022 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2017
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022 - 01/2005
2	N 30IBA 01/2022 - 09/2014
2	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 01/2021
2	LDL CholesterolIBA 11/2021 - 09/2017
2	Amino Acids FDA Link 11/2021 - 10/2011
2	Caffeine (No Doz)FDA LinkGeneric 01/2021 - 01/2018
2	N-Methylaspartate (NMDA)IBA 01/2018 - 08/2008
2	Genetic Markers (Genetic Marker)IBA 12/2017 - 12/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2024
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2024
1	Arginine (L-Arginine)FDA Link 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	gamma-Aminobutyric Acid (GABA)IBA 12/2022
1	Antihypertensive Agents (Antihypertensives)IBA 04/2022
1	Antidepressive Agents (Antidepressants)IBA 04/2022
1	BenzodiazepinesIBA 04/2022
1	Paliperidone Palmitate FDA Link 01/2022
1	Chlorpromazine (Thorazine)FDA Link 01/2022
1	NucleosidesIBA 11/2021
1	pyridineIBA 11/2021
1	didesipramineIBA 11/2021
1	Carboxylic AcidsIBA 11/2021
1	CatecholaminesIBA 11/2021
1	HDL CholesterolIBA 11/2021
1	TetrapyrrolesIBA 11/2021
1	methylxanthineIBA 01/2021
1	Theophylline (Theon)FDA LinkGeneric 01/2021
1	1,7-dimethylxanthine (paraxanthine)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 11/2020
1	ProlactinIBA 01/2020
1	Amisulpride (Solian)IBA 01/2020
1	ThioredoxinsIBA 12/2018
1	Glutathione PeroxidaseIBA 12/2018
1	PeroxiredoxinsIBA 12/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2017
1	NexusIBA 11/2016
1	PhosphoenolpyruvateIBA 10/2015
1	Fish OilsIBA 01/2015
1	Protons (Proton)IBA 02/2012
1	Sulfhydryl Compounds (Thiols)IBA 10/2011
1	Aripiprazole (Abilify)FDA Link 01/2011

Therapy/Procedure

3	Therapeutics 10/2021 - 10/2007
3	Drug Therapy (Chemotherapy) 01/2021 - 05/2003
2	Aftercare (After-Treatment) 01/2022 - 10/2005
2	Treatment Delay 01/2021 - 02/2015
1	Duration of Therapy 04/2022
1	Patient Readmission 01/2022